SCHEMBL29617490

SCHEMBL29617490

N#Cc1ccc(NC(=O)c2cccc3cc[nH]c23)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.56
IKBKB O14920 1/20 0.45
CHUK O15111 1/20 0.45
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
KEAP1 Q14145 1/20 0.44
PDPK1 O15530 1/20 0.43
PKM P14618 1/20 0.42
DHPS P49366 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
KMT2A Q03164 1/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24460229 1.00 GRM5 (0.56) GRM5IKBKBCHUKPDK1PDK2
SCHEMBL24460231 0.86 GRM5 (0.50) GRM5IKBKBCHUKKEAP1PDPK1
SCHEMBL26980730 0.79 MAPT (0.56) GRM5PDPK1PKMKMT2ARAB9A
SCHEMBL29617483 0.79 MAPT (0.56) GRM5PDPK1PKMKMT2ARAB9A
SCHEMBL24460157 0.74 MEN1 (0.55) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL678335 0.73 MAPT (0.46)
SCHEMBL1499498 0.72 GRM5 (1.00) GRM5KEAP1PDPK1KMT2ARAB9A
SCHEMBL14885885 0.71 TMPRSS4 (0.70) PDK1PDK2PDK3PDK4PDPK1
SCHEMBL30771735 0.71 TMPRSS4 (0.70) PDK1PDK2PDK3PDK4PDPK1
SCHEMBL16147657 0.70 PDK1 (0.44) PDK1PDK2PDK3PDK4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109148-A1 SMALL MOLECULE INHIBITORS OF SARS-COV-2 INFECTIONS THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2022-05-27 WO claimed
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2024-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections ACE2, ACE, TMPRSS2 GRM5 2856/4885IKBKB 508/4885CHUK 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.